However, experienced clinicians and newborn screening laboratories alike recognize that increased propionylcarnitine is not a perfect disease marker and in some large series, an infant with increased C3 species will more likely be categorized as a false positive vs affected with
ametabolic disorder (1), an outcome far more desirable than the diagnosis of propionic or methylmalonic acidemia.